Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Jianpi Fuzheng Fang is a Traditional Chinese Medicine (TCM) herbal formula developed by the Yueyang Hospital of Integrated Traditional Chinese and Western Medicine. It is primarily investigated for the interventional recovery and secondary prevention of ischemic stroke during the convalescent phase. In TCM theory, the formula is designed to strengthen the spleen (Jianpi) and support the body's resistance (Fuzheng), addressing underlying deficiencies often associated with chronic recovery. Clinical studies, such as ChiCTR1900026074, evaluate its efficacy and safety when used in combination with standard Western medicine secondary prevention protocols over a 6-month period.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Jianpi Fuzheng Fang (Yueyang Hospital of Integrated Traditional Chinese and Western Medicine).